ProgramPreliminary programme
Keynote lectures
Shai Izraeli, University of Tel-Aviv, Pediatric Hemato-Oncology, Schneider Children Medical Center, Petach Tiqva, Israel A tale of two ETS factors and their roles in leukemogenesis
Confirmed speakers
Isidro Sánchez-García, Instituto de Biología Molecular y Celular del Cáncer-IBMCC (CSIC-USAL). Salamanca, Spain A consensus model for the causation of childhood B cell precursor ALL
Elisa Laurenti, Wellcome - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge Functional and molecular diversity of the human haematopoietic stem cell compartment
Karl Balabanian, Institut Saint-Louis, Université Paris Cité, INSERM U1160, Paris CXCR4 signaling, a gatekeeper orchestrating the specification of hematopoietic multipotent progenitors and skeletal stromal cells
Simon Haas, Max-Delbrück-Centrum für Molekulare Medizin (MDC), Germany Single-cell and spatial multi-omics approaches of the hematopoietic system in health and disease
Véronique Maguer Satta, CRCL, Lyon, UMR5286-U1052 Alteration of the BMP signaling in stem cells and their niche contribute to cancer initiation and could result from environmental pollutant exposure
Nina Cabezas-Wallscheid, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany Regulation of dormant hematopoietic stem cells
Paul Bourgine, University of Lund, Sweden Personalized engineering of human hematopoietic niches
Karen Keeshan, Paul O'Gorman Leukaemia Research Centre, Glasgow, Scotland Modelling paediatric AML to uncover age-specific mechanisms and therapies
Thomas Mercher, INSERM and Institut Gustave Roussy, Villejuif Models and molecular mechanisms of childhood megakaryoblastic leukemia
Session « Young PI»
Bérangère de Laval, Centre d’immunologie de Marseille Luminy (CIML), Marseille Immune response and memory of hematopoietic stem cell.
Delphine Potier, Centre d’immunologie de Marseille Luminy (CIML), Marseille Using scRNAseq to investigate physiological and pathological development of lymphocytes: from fundamental to clinical applications
Laura Poillet, Centre de recherches en cancérologie de Toulouse (CRCT) Toulouse Role of host autophagy in leukemia metabolism and resistance |
Online user: 2 | Privacy |